Rating History for Immix Biopharma, Inc. (IMMX) by Morgan Stanley
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/25/2026 | Judah Frommer | New Coverage | Overweight (N/A) |
20.00 (N/A) |
8.81 (10.25) |
16.35% | Details |
